Pre-clinical drug screen reveals topotecan, actinomycin D and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.
about
Pre-clinical drug screen reveals topotecan, actinomycin D and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Pre-clinical drug screen revea ...... for ETMR brain tumor patients.
@en
type
label
Pre-clinical drug screen revea ...... for ETMR brain tumor patients.
@en
prefLabel
Pre-clinical drug screen revea ...... for ETMR brain tumor patients.
@en
P2093
P2860
P356
P1433
P1476
Pre-clinical drug screen revea ...... for ETMR brain tumor patients.
@en
P2093
Andrey Korshunov
Benjamin Schwalm
Christin Schmidt
Florian Selt
Jennifer A Chan
Marcel Kool
Nil A Schubert
Norman Mack
Sebastian Brabetz
P2860
P356
10.1093/NEUONC/NOX093
P577
2017-05-08T00:00:00Z